Navidea Biopharmaceuticals, Inc.
NAVB
$0.0001
$0.000.00%
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -16.00% | 1,773.14% | -97.22% | -52.83% | -35.89% |
| Total Receivables | -80.09% | 48.50% | -73.23% | -99.35% | 43.31% |
| Inventory | 137.72% | 45.93% | 42.60% | 182.61% | 8.33% |
| Prepaid Expenses | -2.33% | -28.53% | 0.70% | -14.11% | -22.43% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -11.70% | 498.32% | -48.46% | -40.48% | -33.40% |
|
|
|||||
| Total Current Assets | -11.70% | 498.32% | -48.46% | -40.48% | -33.40% |
| Net Property, Plant & Equipment | -35.63% | -34.01% | -40.87% | -37.43% | -34.91% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 13.11% | 19.19% | 26.06% | 27.30% | 19.08% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -62.89% | -94.81% | -94.81% | -94.81% | -86.00% |
| Total Assets | -8.94% | 228.31% | -34.27% | -34.21% | -30.15% |
|
|
|||||
| Total Accounts Payable | 19.10% | -17.26% | 102.64% | 49.34% | 44.13% |
| Total Accrued Expenses | -33.19% | 116.88% | 108.08% | 107.66% | 99.67% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 4,513.55% | 1,030.15% | 13.23% | -22.84% | -92.23% |
| Total Finance Division Other Current Liabilities | -21.02% | 16.73% | 48.51% | 1,864.71% | -- |
| Total Other Current Liabilities | -21.02% | 16.73% | 48.51% | 1,864.71% | -- |
| Total Current Liabilities | -5.39% | 56.07% | 88.77% | 87.59% | 105.86% |
|
|
|||||
| Total Current Liabilities | -5.39% | 56.07% | 88.77% | 87.59% | 105.86% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -82.35% | -76.19% | -92.04% | -93.60% | -94.14% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 0.00% | 0.00% | -12.50% | 0.00% | 0.00% |
| Total Liabilities | -20.56% | 33.54% | 108.61% | 107.89% | 126.41% |
|
|
|||||
| Common Stock & APIC | 0.81% | 2.78% | 2.23% | 2.40% | 2.43% |
| Retained Earnings | -0.36% | -1.83% | -4.20% | -4.64% | -4.74% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 34.01% | 76.19% | -309.67% | -7,813.51% | -245.76% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -100.00% | -100.00% | -100.00% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -100.00% | -100.00% | -100.00% |
|
|
|||||
| Total Common Equity | 34.01% | 76.19% | -309.67% | -7,813.51% | -245.76% |
| Total Preferred Equity | -- | -- | -100.00% | -100.00% | -100.00% |
| Total Minority Interest | 0.00% | 0.00% | 0.00% | -60.00% | -60.00% |
| Total Equity | 36.15% | 81.45% | -352.62% | -1,403.55% | -212.90% |
|
|
|||||
